Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.

Boot BP, Partridge B, Hall W. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people. Neurocase. 2012 Jun; 18(3):181-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.